Position in LH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,081,120
+$467,983 QoQ
Shares Held
11,004
+12.4% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#310
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NewEdge Advisors, LLC holds $58,986,020 across 23 Diagnostics & Research names. LH ranks #7 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
54,764 | $10,431,446 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
19,936 | $9,995,112 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
14,787 | $7,784,468 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
35,788 | $6,914,957 | |
| 5 | NTRA |
Natera, Inc.
|
23,730 | $6,441,508 | |
| 6 | A |
Agilent Technologies, Inc.
|
28,456 | $3,779,810 | |
| 7 | LH |
Labcorp Holdings Inc.
This page
|
11,004 | $3,081,120 | |
| 8 | DGX |
Quest Diagnostics Inc
|
12,508 | $2,651,070 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,081,120 | 11,004 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,613,137 | 9,794 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $2,460,380 | 9,807 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $2,618,848 | 9,123 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $2,022,377 | 7,704 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,988,996 | 8,546 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,565,109 | 6,825 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $64,138 | 287 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $58,407 | 287 | Shares | Sole | 2024-08-16 | |
| No filing history on record for this holder in this stock. | ||||||